📢 Rahul Gandhi's NEET move faces test in Jharkhand

Students in Jharkhand are protesting alleged irregularities in recruitment exams against the Hemant Soren government. Congress, an ally, is now in a tricky spot as students march towards the state assembly. The protests center on the 14th JPSC Civil Services Examination and JSSC exams. Congress has supported the students, urging Soren to form a ministerial committee for dialogue. This tests the party's stance after making exam integrity a national issue. ⚖️

🇮🇳 Ravi Kishan's daughter joins Army, Madhavan impressed

Ravi Kishan’s daughter, Ishita Shukla, chose the Indian Army instead of Bollywood after joining under the Agnipath scheme in 2023. She is from the entertainment industry, with her father being a prominent actor in India. Reports indicated she was a Mahila Agniveer and trained as an NCC cadet before this decision. Actor Madhavan shared his admiration for her choice on his Instagram Story. This reminds people of R Madhavan's past NCC training and his consideration of a military career. 🫡

🛵 Royal Enfield Himalayan 440 coming soon

Royal Enfield is set to revive its older ADV in the form of the Himalayan 440, which might launch as early as September 2026. This new model is expected to offer a more affordable alternative to the existing Himalayan 450. The Scram 440 currently costs Rs 2.32 lakh (Ex-sh), positioning the Himalayan 440 around Rs 2.5 lakh (Ex-sh). It will likely retain the barebones look of the old Himalayan, possibly featuring a 21-inch front wheel. The bike is expected to carry forward attributes like 200mm suspension travel and a 15L fuel tank. 🛵

⛪ Church ownership clash sparks police cases in Kerala

Police have registered two cases against factions of the Syrian Jacobite and Malankara Orthodox groups. The clash occurred over the ownership of a church at Piramadom near Kochi, Kerala. On Sunday night, 10 people from the Jacobite faction and 12 from the Orthodox faction were charged. This stemmed from both sides claiming different court rulings favored their ownership claims. Authorities have deployed police to prevent more violence and called a meeting to settle the long-running dispute.

🎬 CINTAA members quit over leadership drama

Eight elected members of CINTAA's Executive Committee resigned immediately due to a loss of confidence in the association's current operations. The resignations were submitted to General Secretary Upasana Singh, who confirmed 11 members stepped down in total. These members alleged that Poonam Dhillon and Padmini Kolhapure were central to decision-making power grabs. Specific concerns included independent decisions by Dhillon and the use of unapproved lawyers during official meetings. The members are now demanding fresh elections for the body. 😠

🧠 Real Madrid's quiet summer pick making waves

Real Madrid has made six signings this summer, including Bernardo Silva, under new manager Jose Mourinho. The Portuguese midfielder joined Los Blancos on a free transfer from Manchester City. His debut against Ferencvaros showed his football intelligence and ability to control the midfield. While not a flashy signing, Bernardo brings crucial composure and possession retention to the team. His role becomes even bigger now that the Rodri transfer fell through.

⚽ Rodri move to Barcelona nearing final stages

Barcelona is very close to finalizing the signing of midfielder Rodri from Manchester City. The agreement between Barcelona and Rodri is already set, and the focus is now on the final transfer fee negotiation. Negotiations between the two clubs have made significant progress, considerably reducing the initial gap in demands. This means the deal is in its final phase, with only minor details left to resolve for an official announcement. Hansi Flick could potentially have Rodri in training this week if remaining issues are quickly sorted. ⏳

📱 Google's Pixel 11 series drops August 12

Google plans to unveil the Pixel 11 series, Pro Fold, and Watch 5 on August 12 in New York. The lineup includes the Pixel 11, Pro, Pro XL, and Pro Fold, alongside the Pixel Watch 5 and potentially the Pixel Tag. These devices are expected to run on the Tensor G6 processor, featuring new AI capabilities and components like Pixel Glow. The Pixel 11 Pro XL might feature a battery over 5,000 mAh, while the Pro Fold has an 8-inch internal display. Pre-orders for the Pixel 11 series will commence on the launch day.

✨ Mrunal Thakur addresses Yashasvi Jaiswal dating buzz

Mrunal Thakur recently denied dating rumors with cricketer Yashasvi Jaiswal after being spotted together in Mumbai's Bandra West. The 34-year-old actress posted a viral selfie captioned, "Romancing the softness I once tried to hide," gaining massive fan appreciation. She previously dismissed the speculation by questioning where they were together and advising people to focus on real issues. The post allowed her to embrace her natural self, leading to fans showering her with positive comments. This viral moment solidified her public image while addressing media gossip.

🔬 Younger age doesn't mean breast cancer is always aggressive

Breast cancer diagnoses are rising sharply in younger women, leading to perceptions of greater aggression. Professor Lee Ji-eun stated that youth alone does not automatically equate to a more aggressive disease form. However, subtypes like triple-negative and HER2-positive cancers are more common in those aged 15 to 39 than those aged 50 and older. Physicians stress that the cancer's subtype and stage are more critical than age for treatment decisions. New targeted therapies and strategies are changing outcomes for aggressive cancers, urging patients to focus on their specific diagnosis.

🔬 New drug targets cancer DNA mutations

CINDELA has been developed to specifically target cancer-related DNA mutations. This breakthrough was announced by researchers at a major oncology institute. The drug showed promising results in initial trials conducted in early 2024. It aims to combat various forms of cancer by disrupting harmful genetic changes within cells. Further clinical trials are scheduled to test its efficacy across different patient groups.